Catalyst Wire Dossier Catalyst Wire Dossier

mFOLFIRINOX

Drug timelines are a Plus or Pro feature.

25 regulatory and trial events tracked for mFOLFIRINOX, covering 2019-11-13 to 2026-06-25. Get the full timeline:

Most recent: Clinical Trial Results: mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma [Phase 2]

See pricing